Synovics Pharmaceuticals, Inc.

Synovics Pharmaceuticals, Inc.

Share · US87163M1018 (OTC)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Synovics Pharmaceuticals, Inc.
No Price
Closing Price OTC 28.04.2026: 0,0001 USD
28.04.2026 20:00
Current Prices from Synovics Pharmaceuticals, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
SYVC
USD
28.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for Synovics Pharmaceuticals, Inc. Share
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.

Company Data

Name Synovics Pharmaceuticals, Inc.
Company Synovics Pharmaceuticals, Inc.
Website https://www.synovics.com
Primary Exchange OTC UTC
ISIN US87163M1018
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO John R. Palmer
Country United States of America
Currency USD
Employees 0,2 T
Address 5360 Northwest 35th Avenue, Fort Lauderdale
IPO Date 2023-06-26

Stock Splits

Date Split
30.05.2001 1:5

Ticker Symbols

Name Symbol
Over The Counter SYVC
More Shares
Investors who hold Synovics Pharmaceuticals, Inc. also have the following shares in their portfolio:
EQUITY RELEASE FUNDING (NO.4) PLC A1 MTG BKD FRN 30/07/39 £(VAR)(BR)(REGS)
EQUITY RELEASE FUNDING (NO.4) PLC A1 MTG BKD FRN 30/07/39 £(VAR)(BR)(REGS) Bond
FLOWSERVE 20/30
FLOWSERVE 20/30 Bond